Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenetics: yeast lead the way.

Eric Foss1, Antonio Bedalov

  • 1Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, Washington 98109, USA.

Chemistry & Biology
|April 28, 2006
PubMed
Summary

Researchers studied genetically diverse yeast strains to understand how cells respond to small molecules. Findings indicate that drug responses are controlled by a few key genetic loci, enabling the grouping of similar molecules.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromatin architecture sets origin licensing capacity.

Research square·2026
Same author

Chromatin architecture sets origin licensing capacity.

bioRxiv : the preprint server for biology·2026
Same author

Proteasome-dependent degradation and nucleus-vacuole junctions sustain proteostasis during acute glucose starvation.

bioRxiv : the preprint server for biology·2026
Same author

Roles of RRM2 and RRM2B in pyrimidine stress responses and differentiation of acute myeloid leukemia cells.

Cell death discovery·2026
Same author

Sir2 and Fun30 regulate ribosomal DNA replication timing via MCM helicase positioning and nucleosome occupancy.

eLife·2025
Same author

Quiescent cells maintain active degradation-mediated protein quality control requiring proteasome, autophagy, and nucleus-vacuole junctions.

The Journal of biological chemistry·2024

Area of Science:

  • Genetics
  • Molecular Biology
  • Pharmacology

Background:

  • Investigating the genetic underpinnings of cellular responses to small molecules is crucial for understanding drug efficacy and toxicity.
  • Previous studies have explored genetic variation in model organisms, but a comprehensive analysis linking genetic diversity to small molecule response in yeast was lacking.

Discussion:

  • Perlstein et al. utilized genetically diverse yeast strains to dissect the genetic architecture of cellular responses to a panel of small molecules.
  • The study identified a limited number of quantitative trait loci (QTLs) significantly associated with variations in drug response phenotypes.
  • These findings highlight the polygenic nature of drug response, yet emphasize the major contribution of a few key genetic factors.

Key Insights:

  • Cellular responses to small molecules, including drugs, are predominantly regulated by a small number of genetic loci.
  • This genetic framework allows for the effective clustering of small molecules based on their functional similarity in cellular effects.
  • The identified loci provide potential targets for predicting drug response and understanding mechanisms of drug action.

Outlook:

  • Future research can leverage this system to predict individual yeast strain responses to novel compounds.
  • This approach may be extended to other model organisms and complex biological systems to understand personalized medicine.
  • Further characterization of the identified loci will elucidate the specific molecular pathways involved in small molecule sensitivity.

Related Experiment Videos